Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatmentMult Scler Relat Disord 2023 Aug 25;79(xx)104949, S Sen, A Tuncer, M Terzi, SD Bunul, P Ozen-Acar, B Altunrende, S Ozakbas, M Tutuncu, U Uygunoglu, G Akman-Demir, R Karabudak, H Efendi, A Siva
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.